Overview
Hepatitis C is one of the few chronic illnesses that we have the potential to cure. The new primary care HCV initiative supports SFHN primary care providers initiating and monitoring primary-care based hepatitis C treatment.
This toolkit is available to provide additional resources. For patient-specific questions please use e-referral.
Presentations
HCV for Quarterly Providers
HCV Training Nitty Gritty
Dr Colleen Lynch provides a background on the impact of HCV nationally and in our system. She provides an overview of treatment priority patients, common regimens and drug-drug interactions.
Obtaining medications
Dr Kelly Eagen walks through a case. She discusses expectation setting for patients, treatment priority patients, and provides examples of persuasive language for prior authorization letters.
Ribavirin Monitoring
Dr Luetkemeyer outlines the specifics of and monitoring of patients who require ribarivin, including the strict 6 month rule of no conceiving or causing a pregnancy.
Team-based care HCV Treatment
In this slide show, Dr Kelly Eagen reviews the Tom Waddell Urban Health Center model for initiation and monitoring of Hepatitis C treatment.
Links
• HCV Guidance: Recommendations for Testing, Managing, & Treating Hepatitis Cz:http://www.hcvguidelines.org/
• EASL Recommendations on Treatment of Hepatitis C 2015:http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf
• VA HCV website: http://www.hepatitis.va.gov/provider/index.asp (Handouts for patients regarding how to take medications & manage side effects)
• HCV drug-drug interactions: www.hep-druginteractions.org
• HIV drug-drug interactions: www.hiv-druginteractions.org
• HCV drug-drug interaction tables & news: http://hcvdruginfo.ca/
• CYP drug interaction table: http://Medicine.iupui.edu/clinpharm/ddis
• General info: http://www.micromedexsolutions.com/micromedex2/librarian/
Package inserts:
o Daclatasvir: http://www.micromedexsolutions.com/micromedex2/librarian/
o Simprevir: http://www.olysio.com/
o Sofosbuvir: http://www.sovaldi.com/
o Sofosbuvir+Ledipsavir coformulation: http://www.harvoni.com/
o OBV/PTV/RTV + DSV: http://www.rxabbvie.com/pdf/viekirapak_pi.pdf
Zepatier
UW Hepatitis C Resource Page
This website provides APRI and FIB-4 calculators, online courses and guidelines for management of liver disease.
Upcoming CME
San Francisco HCV Community Provider monthly meeting
(First Mondays, 6-8 pm @ SFGH)
Email Amanda.newstetter@ucsf.edu to join the group listhost
Meet with community providers treating HCV to review and learn about current and upcoming regimens, discuss challenging cases, learn about innovative care delivery models and share tips to obtain medications. Participants benefit by developing relationships with other providers in SF treating HCV in the primary care setting.
• AASLD The Liver Meeting
November 11-15, 2016
Boston, MA
AASLD Link
• UCSF Medical Management of HIV and Hepatitis
December 8-10, 2016
San Francisco, CA
UCSF Link
Please note, you must obtain permission from your supervisor to use continuing education time, floating holidays or leave to attend any of the above listed trainings.
For trainings noted *, we anticipate a limited amount of funding to support staff involved in primary care-based HCV treatment for registration costs. If interested in attending, please email Katie Burk (SFDPH Viral Hepatitis Coordinator, katie.burk@sfdph.org) with your name, title, clinical sites and interest. Do not register for trainings until notified that the HCV Initiative can provide funding for you. You will receive instructions on how to register once approved.